Freeline Therapeutics, a company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announced the pricing of its initial public offering in the United States. Freeline Nasdaq IPO is UCL Technology Fund's 3rd IPO since its inception in 2016.
Andrew Elder, Deputy Managing Partner AlbionVC discusses why alternative assets such as venture capital are a good home in a post pandemic world.
Bramble Energy, a UCL Technology Fund portfolio spin-out, is the world’s most scalable hydrogen fuel cell company has raised a £5m Series A round from a combination of new and existing investors.
UCL Technology Fund announces first close of £100m fund 2. Fund 2 follows the successes of the first fund and is committed to bring UCL’s academic research in life, computer and physical sciences to commercial reality.
Humanloop, a game changing UCL spinout, has attracted investment from UCL’s Technology Fund to enable AI systems to query human experts on only the most valuable data and learn much faster.
Robert Whitby-Smith, AlbionVC partner chats with Computer Weekly about the importance of resilience for start-ups during the post covid-19 recession.